secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001425450-23-000111
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics reports record Q3 revenue of $40.0M, up 14% YoY; raises adj. EBITDA guidance
--------------------------------------------------------------------------------

- Total revenue $40.0M (+14% YoY); U.S. revenue $29.4M (+11%), international $10.6M (+26%).
- Trauma & Deformity revenue $28.8M (+21%); Scoliosis $10.3M (+3%); Sports Med/Other $0.9M (-20%).
- Net loss of $4.6M vs net income of $18.5M in prior year; adjusted EBITDA record $3.6M (vs $1.9M).
- Full-year 2023 revenue guidance reiterated at $148-151M; adj. EBITDA guidance raised to $4-5M.
- Consigned $3.9M of sets in Q3 (vs $6.4M in Q3 2022); cash $84.0M with no credit line drawn.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545023000111/0001425450-23-000111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545023000111/kids-20231106.htm
  HTML page:      https://secwatch.observer/filing/0001425450-23-000111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer